Beamz Interactive, Inc.
BZIC
Other OTC0.00
USD
- -
- -
Beamz Interactive, Inc.
BZIC
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Beamz Interactive, Inc. (BZIC) develops and sells interactive laser controller technology that enables users of all ages and skill levels to create and play music through laser beams, targeting applications in music, gaming, education, therapy, senior care, lighting, and consumer entertainment. The company's core products include the Beamz Professional Edition for educational and therapeutic settings; Beamz Home Edition for consumer use; Beamz By Flo consumer product family; stand-alone software applications compatible with PCs, Macs, iPhones, iPads, and Android devices; and interactive music libraries with hundreds of songs, instruments, vocals, and effects accessible without musical training. Products are distributed online, directly to education markets, and through reseller partnerships such as with The Learning Station, Gigglebellies, Spectronics in Australia and New Zealand, and Westminster Technologies in the U.S. assistive technology sector; the Beamz player features four laser beams that trigger synchronized sounds when hands pass through them. Founded in 2001 and headquartered at 15354 North 83rd Way, Suite 101, Scottsdale, Arizona, the company operates worldwide with a focus on leisure products in the consumer durables sector and holds multiple patents on its interactive music software, laser controllers, and related designs. Recent developments include the 2014 launch of the Beamz Therapy Bundle with a guide developed in partnership with Temple University's Department of Rehabilitation Sciences, featuring 50 songs, Beamz Studio software, and protocols for therapy applications; completion of private equity financing via Chardan Capital Markets to support education and healthcare expansion; and engagements like investor relations with Trilogy Capital Partners, alongside international distribution growth into Europe, Australia, New Zealand, and assistive markets.